Vikash Bhagwandin
Company: VincaStemyx
Job title: Founding Scientist, Novel ADC Payloads
Seminars:
Uncovering the Promise of GEMMs in Therapeutic Discovery 11:15 am
Overcoming challenges to develop this model including tumor heterogeneity, and recapitulating the tumor microenvironment for therapeutic discovery Implementing high-throughput screening methods on this model for drug discovery Spotlighting the translatable potential this approach could have for different therapeutic modalities including small molecules and ADCsRead more
day: Conference Day One - Track 1 - AM
Chair’s Closing Remarks & End of Summit 3:15 pm
day: Conference Day Two
Fireside Chat: Assessing the Future of Preclinical Tumor Models 1:30 pm
Discussing the exciting model developments that have recently gained traction Uncovering the use of models for precision oncology and/or for personalized patient treatment regimes Reflecting on the field’s current challenges and how to move forward in increasing model predictability and improving clinical translation rates Moderated by: Vikash BhagwandinRead more
day: Conference Day Two
Chair’s Opening Remarks 8:50 am
day: Conference Day Two
Plenary Panel: How Do You Select the Best Model for Your Study & Achieve the Best Balance of Preclinical Tumor Models? 8:30 am
Understanding how to combine different tumour models for a study and leveraging them to get the optimal results Lessons learned dealing with costs rising, logistical challenges and more Addressing the need to fill the current gap with potential models with better translatabilityRead more
day: Conference Day One